Biologically plausible and evidence-based risk intervals in immunization safety research.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-12-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2012.07.024PMID 22835735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

  2012cited by this paper
• Influenza Vaccine Safety in Children Less Than 5 Years Old: The 2010 and 2011 Experience in Australia

  2012cited by this paper
• Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine

  2011cited by this paper
• Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice

  2011cited by this paper
• Adverse Effects of Vaccines

  2011cited by this paper
• Identifying optimal risk windows for self‐controlled case series studies of vaccine safety

  2011cited by this paper
• Understanding the Role of Human Variation in Vaccine Adverse Events: The Clinical Immunization Safety Assessment Network

  2011cited by this paper
• Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine.

  2011cited by this paper
• Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months

  2010cited by this paper
• Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants: A Randomized Double-Blind Placebo-Controlled Study

  2010cited by this paper
• Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors.

  2010cited by this paper
• Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

  2010cited by this paper
• Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

  2010cited by this paper
• Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan.

  2010cited by this paper
• Vaccines for preventing influenza in healthy adults.

  2010cited by this paper
• Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.

  2009cited by this paper
• Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

  2009cited by this paper
• Evaluation of the cases with acute disseminated encephalomyelitis

  2009cited by this paper
• Acute disseminated encephalomyelitis: postinfectious, postimmunization and variant forms

  2009cited by this paper
• The methodology of self-controlled case series studies

  2009cited by this paper
• Comparison of epidemiologic methods for active surveillance of vaccine safety.

  2008cited by this paper
• Febrile seizures

  2007cited by this paper
• Live attenuated versus inactivated influenza vaccine in infants and young children.

  2007cited by this paper
• Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

  2007cited by this paper
• Acute Disseminated Encephalomyelitis

  2007cited by this paper
• Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

  2007cited by this paper
• Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

  2007cited by this paper
• Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.

  2006cited by this paper
• Acute disseminated encephalomyelitis: a follow-up study in Taiwan

  2006cited by this paper
• Tutorial in biostatistics: the self‐controlled case series method

  2006cited by this paper
• Adverse events reported following live, cold-adapted, intranasal influenza vaccine.

  2005cited by this paper
• Acute Disseminated Encephalomyelitis An Update

  2005cited by this paper
• Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar) administered in previously unvaccinated Spanish children aged 24 to 36 months.

  2005cited by this paper
• Fever following immunization

  2005cited by this paper
• Acute disseminated encephalomyelitis: an update.

  2005cited by this paper
• Control without separate controls: evaluation of vaccine safety using case-only methods.

  2004cited by this paper
• Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

  2004cited by this paper
• Guillain-Barré syndrome following influenza vaccination

  2004cited by this paper
• Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

  2004cited by this paper
• MMR vaccination and pervasive developmental disorders: a case-control study.

  2004cited by this paper
• Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

  2004cited by this paper
• Acute disseminated encephalomyelitis in children: clinical features and HLA‐DR linkage

  2003cited by this paper
• Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.

  2002cited by this paper
• Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients

  2002cited by this paper
• A Population-Based Study of Measles, Mumps, and Rubella Vaccination and Autism

  2002cited by this paper
• Febrile Seizures

  2002cited by this paper
• A population-based study of measles, mumps, and rubella vaccination and autism.

  2002cited by this paper
• Acute disseminated encephalomyelitis in children.

  2002cited by this paper
• Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.

  2001cited by this paper
• MMR and autism: further evidence against a causal association.

  2001cited by this paper
• Statistical assessment of the association between vaccination and rare adverse events post-licensure.

  2001cited by this paper
• Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children

  2001cited by this paper
• Postlicensure safety surveillance for varicella vaccine.

  2000cited by this paper
• Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children.

  2000cited by this paper
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2000cited by this paper
• Vaccines for preventing influenza in healthy adults.

  2000cited by this paper
• Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

  2000cited by this paper
• The postmarketing safety profile of varicella vaccine.

  2000cited by this paper
• Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants

  1998cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center.

  1996cited by this paper
• Relative incidence estimation from case series for vaccine safety evaluation.

  1995cited by this paper
• Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains).

  1995cited by this paper
• Spatial disease clusters: detection and inference.

  1995cited by this paper
• The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children.

  1991cited by this paper
• Neurologic complications of Semple‐type rabies vaccine

  1987cited by this paper
• Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.

  1976cited by this paper
• Neurologic disorders following live measles-virus vaccination.

  1973cited by this paper
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children

  year unknowncited by this paper

• A review of methodologic & data considerations for vaccine safety surveillance in the wake of the COVID-19 pandemic.

  2025cites this paper
• Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination.

  2024cites this paper
• Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

  2024cites this paper
• Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.

  2024cites this paper
• Recurrent Acute Disseminated Encephalomyelitis (ADEM) after COVID-19-vaccination and after subsequent COVID-19-infection: A case report (part II)

  2023cites this paper
• Risk of herpes zoster ophthalmicus after COVID-19 vaccination in a large US healthcare claims database.

  2023cites this paper
• Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine.

  2023cites this paper
• Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform

  2022cites this paper
• Safety of routine childhood vaccine coadministration versus separate vaccination

  2022cites this paper
• Transverse myelitis and coronavirus disease 2019 vaccine: A temporal association

  2021cites this paper
• Acute disseminated encephalomyelitis and routine childhood vaccinations – a self-controlled case series

  2021influential citation
• No association between enterovirus 71 (EV71) vaccination and risk of febrile seizures: a population-based near real-time surveillance study

  2021cites this paper
• Developmental outcomes following vaccine-proximate febrile seizures in children

  2020cites this paper
• Fever After Influenza, Diphtheria-Tetanus-Acellular Pertussis, and Pneumococcal Vaccinations

  2020cites this paper
• Vaccinations Do Not Increase Arthritis Flares in Juvenile Idiopathic Arthritis: A Study of the Relationship between Routine Childhood Vaccinations on the Australian Immunisation Schedule and Arthritis Activity in Children with Juvenile Idiopathic Arthritis

  2020cites this paper
• Postvaccination Febrile Seizure Severity and Outcome

  2019cites this paper
• Sequential surveillance for drug safety in a regulatory environment

  2018cites this paper
• Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

  2018cites this paper
• A multi-site feasibility study to assess fever and wheezing in children after influenza vaccines using text messaging.

  2017cites this paper
• Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view.

  2017cites this paper
• Statistical Power for Postlicensure Medical Product Safety Data Mining

  2017cites this paper
• The Risk of Febrile Seizures Following Influenza and 13-Valent Pneumococcal Conjugate Vaccines

  2017cites this paper
• Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine

  2016cites this paper
• Assessing Fever Frequency After Pediatric Live Attenuated Versus Inactivated Influenza Vaccination

  2016cites this paper
• Vaccines and Kawasaki disease

  2016cites this paper
• Febrile Seizure Risk After Vaccination in Children 6 to 23 Months

  2016cites this paper
• Sudden-Onset Sensorineural Hearing Loss after Immunization

  2016cites this paper
• Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

  2016cites this paper
• Febrile Seizures After 2010–2011 Trivalent Inactivated Influenza Vaccine

  2015cites this paper
• The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

  2015cites this paper
• Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System

  2015cites this paper
• Safety of Measles-Containing Vaccines in 1-Year-Old Children

  2015cites this paper
• Timely Versus Delayed Early Childhood Vaccination and Seizures

  2014cites this paper
• Risk of febrile seizures after first dose of measles–mumps–rubella–varicella vaccine: a population-based cohort study

  2014cites this paper
• Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine.

  2014cites this paper
• Systemic immunotoxicity reactions induced by adjuvanted vaccines.

  2014cites this paper
• Exploring the risk factors for vaccine-associated and non-vaccine associated febrile seizures in a large pediatric cohort.

  2014cites this paper
• Integrating database knowledge and epidemiological design to improve the implementation of data mining methods that evaluate vaccine safety in large healthcare databases

  2014cites this paper
• Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers

  2013cites this paper
• Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010

  2013cites this paper
• Guillain-Barré Syndrome , Influenza Vaccination , and Antecedent Respiratory and Gastrointestinal Infections : A Case

  2013cites this paper
• Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study

  2013cites this paper
• Kaiser Permanente Vaccine Study Center: Highlights of 2009–2012

  2013cites this paper
• Lack of association of Guillain-Barré syndrome with vaccinations.

  2013cites this paper
• Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines.

  2013cites this paper
• Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.

  2013cites this paper
• Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009–2011

  2013cites this paper